Follow
Seyed Hadi Poormoghim
Seyed Hadi Poormoghim
Verified email at iums.ac.ir
Title
Cited by
Cited by
Year
Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty‐eight patients
H Poormoghim, M Lucas, N Fertig, TA Medsger Jr
Arthritis & Rheumatism: Official Journal of the American College of …, 2000
3782000
Systemic sclerosis: Comparison of efficacy of oral cyclophosphamide and azathioprine on skin score and pulmonary involvement—A retrospective study
H Poormoghim, N Rezaei, Z Sheidaie, AR Almasi, M Moradi-Lakeh, ...
Rheumatology international 34, 1691-1699, 2014
462014
Cyclophosphamide for scleroderma lung disease: a systematic review and meta-analysis
H Poormoghim, M Moradi Lakeh, M Mohammadipour, F Sodagari, ...
Rheumatology international 32, 2431-2444, 2012
462012
KIR3DL1+HLA‐B Bw4 Ile80 and KIR2DS1+HLA‐C2 combinations are both associated with ankylosing spondylitis in the Iranian population
N Tajik, F Shahsavar, H Poormoghim, MF Radjabzadeh, T Mousavi, ...
International journal of immunogenetics 38 (5), 403-409, 2011
462011
The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort
MG Lazzaroni, E Marasco, C Campochiaro, J DeVries-Bouwstra, ...
Rheumatology 60 (11), 5028-5041, 2021
442021
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study
VK Jaeger, M Tikly, D Xu, E Siegert, E Hachulla, P Airò, G Valentini, ...
Rheumatology 59 (7), 1684-1694, 2020
372020
Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis
T Mousavi, H Poormoghim, M Moradi, N Tajik, F Shahsavar, B Asadifar
Iranian Journal of Immunology 7 (2), 88-95, 2010
322010
Phenotypic study of natural killer cell subsets in ankylosing spondylitis patients
T Mousavi, H POURMOGHIM, M MORADI, N Tajik, F Shahsavar, M SOUFI
IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI) 8 (4), 193-198, 2009
322009
Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients
H Poormoghim, AS Moghadam, M Moradi-Lakeh, M Jafarzadeh, ...
Rheumatology international 33, 1943-1950, 2013
302013
Primary hypertrophic osteoarthropathy
H Poormoghim, A Hosseynian, A Javadi
Rheumatology international 32 (3), 607-610, 2012
222012
Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran
H Poormoghim, E Andalib, A Jalali, A Ghaderi, A Ghorbannia, ...
Rheumatology international 36, 925-934, 2016
212016
Gene expression profiling of toll-like receptor 4 and 5 in peripheral blood mononuclear cells in rheumatic disorders: ankylosing spondylitis and rheumatoid arthritis
S Almasi, S Aslani, H Poormoghim, AR Jamshidi, S Poursani, ...
Iranian Journal of Allergy, Asthma and Immunology, 87-92, 2016
172016
Systemic sclerosis and calcinosis cutis: response to rituximab.
H Poormoghim, E Andalib, AR Almasi, E Hadibigi
Journal of Clinical Pharmacy & Therapeutics 41 (1), 2016
142016
Progesterone aggravates lung fibrosis in a mouse model of systemic sclerosis
F Vafashoar, K Mousavizadeh, H Poormoghim, A Haghighi, ...
Frontiers in Immunology 12, 742227, 2021
112021
Preliminary study of cardiovascular manifestations and cardiac severity scale in 58 patients with systemic sclerosis in Iran using the Medsger scale
H Poormoghim, MA Poorkarim, MM Lakeh, BN Heshmati, S Almasi, ...
The Journal of Tehran Heart Center 5 (1), 14, 2010
112010
MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosis
P Bayati, M Kalantari, MA Assarehzadegan, H Poormoghim, N Mojtabavi
Scientific Reports 12 (1), 18932, 2022
102022
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
A Lescoat, D Huscher, N Schoof, P Airò, J de Vries-Bouwstra, ...
Rheumatology 62 (6), 2178-2188, 2023
92023
Cohort enrichment strategies for progressive interstitial lung disease in systemic sclerosis from European Scleroderma Trials and Research
AM Hoffmann-Vold, C Brunborg, P Airò, LP Ananyeva, L Czirják, ...
Chest 163 (3), 586-598, 2023
72023
Aberrant expression of miR-138 as a novel diagnostic biomarker in systemic sclerosis
P Bayati, H Poormoghim, N Mojtabavi
Biomarker Insights 17, 11772719221135442, 2022
72022
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort
M Elhai, N Sritharan, M Boubaya, A Balbir-Gurman, E Siegert, E Hachulla, ...
The Lancet Rheumatology 4 (11), e785-e794, 2022
72022
The system can't perform the operation now. Try again later.
Articles 1–20